These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32792446)

  • 1. The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a
    Boertien TM; Drent ML; Booij J; Majoie CBLM; Stokkel MPM; Hoogmoed J; Pereira A; Biermasz NR; Simsek S; Groote Veldman R; Tanck MWT; Fliers E; Bisschop PH
    BMJ Open; 2020 Aug; 10(8):e038250. PubMed ID: 32792446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanreotide versus placebo for tumour reduction in patients with a
    Boertien TM; Drent ML; Booij J; Majoie CBLM; Stokkel MPM; Hoogmoed J; Pereira AM; Biermasz NR; Simsek S; Veldman RG; Weterings AJ; Vink JM; Tanck MWT; Fliers E; Bisschop PH
    Lancet Reg Health Eur; 2024 Jul; 42():100923. PubMed ID: 39070749
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Boertien TM; Booij J; Majoie CBLM; Drent ML; Pereira AM; Biermasz NR; Simsek S; Veldman RG; Stokkel MPM; Bisschop PH; Fliers E
    Eur J Hybrid Imaging; 2020 Feb; 4(1):4. PubMed ID: 34191241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lanreotide on uptake of
    Aalbersberg EA; de Wit-van der Veen BJ; Versleijen MWJ; Saveur LJ; Valk GD; Tesselaar MET; Stokkel MPM
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):696-703. PubMed ID: 30097670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.
    Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC
    BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-directed [
    Chaman Baz AH; van de Wiel E; Groenewoud H; Arntz M; Gotthardt M; Deinum J; Langenhuijsen J
    BMJ Open; 2022 Aug; 12(8):e060779. PubMed ID: 35998969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the
    Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
    Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of (68)Ga DOTATATE PET/CT for diagnostic assessment and monitoring of (177)Lu DOTATATE therapy in pituitary carcinoma.
    Novruzov F; Aliyev JA; Jaunmuktane Z; Bomanji JB; Kayani I
    Clin Nucl Med; 2015 Jan; 40(1):47-9. PubMed ID: 25275413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma of the Nasopharynx Diagnosed by Gallium 68 DOTATATE Positron Emission Tomography/Computed Tomography.
    Kim S; Dillon WP; Hope TA; El-Sayed IH; van Zante A; Wu K; Masharani U
    World Neurosurg; 2019 May; 125():400-404. PubMed ID: 30797906
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 16. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
    Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
    J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol of the randomised placebo-controlled GLOBE trial:
    Hulst AH; Visscher MJ; Godfried MB; Thiel B; Gerritse BM; Scohy TV; Bouwman RA; Willemsen MGA; Hollmann MW; DeVries JH; Preckel B; Hermanides J
    BMJ Open; 2018 Jun; 8(6):e022189. PubMed ID: 29866735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled trial.
    Paget L; Bierma-Zeinstra S; Goedegebuure S; Kerkhoffs G; Krips R; Maas M; Moen MH; Reurink G; Stufkens S; de Vos RJ; Weir A; Tol JL
    BMJ Open; 2019 Oct; 9(10):e030961. PubMed ID: 31594891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Impact of [
    Wannachalee T; Turcu AF; Bancos I; Habra MA; Avram AM; Chuang HH; Waguespack SG; Auchus RJ
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):288-294. PubMed ID: 31066920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.